{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05890027",
            "orgStudyIdInfo": {
                "id": "20230019"
            },
            "organization": {
                "fullName": "University of Miami",
                "class": "OTHER"
            },
            "briefTitle": "Phenylephrine Versus Eyelid Taping for Muller's Muscle-Conjunctival Resection (MMCR) Evaluation",
            "officialTitle": "Phenylephrine Versus Upper Eyelid Taping For Muller's Muscle Conjunctival Resection Evaluation",
            "therapeuticArea": [
                "Other"
            ],
            "study": "phenylephrine-versus-eyelid-taping-for-muller-s-muscle-conjunctival-resection-mmcr-evaluation"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-03",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-03-19",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-09-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-09-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-05-25",
            "studyFirstSubmitQcDate": "2023-05-25",
            "studyFirstPostDateStruct": {
                "date": "2023-06-05",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-03-22",
            "lastUpdatePostDateStruct": {
                "date": "2024-03-25",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Sara T. Wester",
                "investigatorTitle": "Professor of Clinical",
                "investigatorAffiliation": "University of Miami"
            },
            "leadSponsor": {
                "name": "University of Miami",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "This research study aims to compare whether Phenylephrine 2.5% ophthalmic eye drop solution can serve as a better indicator of the effect of a drooping upper eyelid (ptosis) by covering part of the upper portion of the field of vision as compared to traditional use of tape to lift up the upper eyelid in the evaluation of patients for surgical upper eyelid repair."
        },
        "conditionsModule": {
            "conditions": [
                "Ptosis, Eyelid"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE4"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 30,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Phenylephrine and Eye Taping Group",
                    "type": "EXPERIMENTAL",
                    "description": "Participants in this group will initially have superior visual field testing done with the upper eyelid manually taped. Then, participants will have superior visual field testing done after receiving Phenylephrine 2.5% ophthalmic solution. Participants will be in each group for up to 60 minutes.",
                    "interventionNames": [
                        "Drug: Phenylephrine Ophthalmic",
                        "Other: Eyelid Tape"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Phenylephrine Ophthalmic",
                    "description": "One drop of Phenylephrine 2.5% ophthalmic solution to be administered to the eye with ptosis to evaluate for surgical repair.",
                    "armGroupLabels": [
                        "Phenylephrine and Eye Taping Group"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "Eyelid Tape",
                    "description": "Participants will have the affected eye with ptosis manually lifted using tape.",
                    "armGroupLabels": [
                        "Phenylephrine and Eye Taping Group"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change in ptosis as measured by the tangent screen visual field test",
                    "description": "Change in ptosis as measured by the tangent screen visual field test in meters",
                    "timeFrame": "Baseline, 60 minutes"
                },
                {
                    "measure": "Change in ptosis as measured by the margin to reflex distance 1 (MRD1)",
                    "description": "Change in ptosis as measured by the margin to reflex distance 1 (MRD1) in millimeters by transparent ruler",
                    "timeFrame": "Baseline, 60 minutes"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Individuals diagnosed with ptosis undergoing conjunctival Muller's muscle resection evaluation.\n* Individuals who can tolerate and have no hypersensitivity to phenylephrine 2.5% ophthalmic solution.\n* Individuals who can tolerate eye-drop medications.\n* Individuals who are physically able to take a tangent screen visual field test.\n* Age: Adults who can comprehend the instructions and procedures (18-90 years old).\n\nExclusion Criteria:\n\n- This study will not incorporate any of the following at-risk populations: adults unable to consent, individuals who are not yet adults, pregnant women, prisoners.\n\n* This study will not include participants who refuse to consent.\n* This study will not include participants who are too tired or unable to take a tangent screen visual field test (see Risk to Subjects).\n* This study will not include individuals who may not be able to tolerate phenylephrine 2.5% ophthalmic solution.\n* Specifically, those with a past medical history of bradycardia, hypotension, autonomic dysfunction, or severe cardiovascular disease\n* This study will not include individuals who consume drugs contraindicated in phenylephrine use: Ergot Derivatives (Vasoconstrictive CYP3A4 Substrates), Iobenguane Radiopharmaceutical Products, Kratom, Lisuride, Monoamine Oxidase Inhibitors",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "90 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Sara T Wester, MD",
                    "role": "CONTACT",
                    "phone": "(305)-243-2020",
                    "email": "SWester2@med.miami.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Sara T Wester, MD",
                    "affiliation": "University of Miami",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of Miami Bascom Palmer Eye Institute",
                    "status": "RECRUITING",
                    "city": "Miami",
                    "state": "Florida",
                    "zip": "33136",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Lynn Leveille",
                            "role": "CONTACT",
                            "phone": "925-389-4200",
                            "email": "lal2014@miami.edu"
                        },
                        {
                            "name": "Sara T Wester, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 25.77427,
                        "lon": -80.19366
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000001763",
                    "term": "Blepharoptosis"
                }
            ],
            "ancestors": [
                {
                    "id": "D000005141",
                    "term": "Eyelid Diseases"
                },
                {
                    "id": "D000005128",
                    "term": "Eye Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M14261",
                    "name": "Prolapse",
                    "relevance": "LOW"
                },
                {
                    "id": "M5044",
                    "name": "Blepharoptosis",
                    "asFound": "Ptosis, Eyelid",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8284",
                    "name": "Eyelid Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8271",
                    "name": "Eye Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC11",
                    "name": "Eye Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000010656",
                    "term": "Phenylephrine"
                },
                {
                    "id": "D000010109",
                    "term": "Oxymetazoline"
                }
            ],
            "ancestors": [
                {
                    "id": "D000002316",
                    "term": "Cardiotonic Agents"
                },
                {
                    "id": "D000009184",
                    "term": "Mydriatics"
                },
                {
                    "id": "D000001337",
                    "term": "Autonomic Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000013566",
                    "term": "Sympathomimetics"
                },
                {
                    "id": "D000014662",
                    "term": "Vasoconstrictor Agents"
                },
                {
                    "id": "D000014663",
                    "term": "Nasal Decongestants"
                },
                {
                    "id": "D000019141",
                    "term": "Respiratory System Agents"
                },
                {
                    "id": "D000058646",
                    "term": "Adrenergic alpha-1 Receptor Agonists"
                },
                {
                    "id": "D000000316",
                    "term": "Adrenergic alpha-Agonists"
                },
                {
                    "id": "D000000322",
                    "term": "Adrenergic Agonists"
                },
                {
                    "id": "D000018663",
                    "term": "Adrenergic Agents"
                },
                {
                    "id": "D000018377",
                    "term": "Neurotransmitter Agents"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000020011",
                    "term": "Protective Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M21860",
                    "name": "Pharmaceutical Solutions",
                    "relevance": "LOW"
                },
                {
                    "id": "M13561",
                    "name": "Phenylephrine",
                    "asFound": "Achieved",
                    "relevance": "HIGH"
                },
                {
                    "id": "M13031",
                    "name": "Oxymetazoline",
                    "asFound": "Achieved",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12814",
                    "name": "Ophthalmic Solutions",
                    "relevance": "LOW"
                },
                {
                    "id": "M5572",
                    "name": "Cardiotonic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M12139",
                    "name": "Mydriatics",
                    "relevance": "LOW"
                },
                {
                    "id": "M16345",
                    "name": "Sympathomimetics",
                    "relevance": "LOW"
                },
                {
                    "id": "M17409",
                    "name": "Vasoconstrictor Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M7966",
                    "name": "Ephedrine",
                    "relevance": "LOW"
                },
                {
                    "id": "M27586",
                    "name": "Pseudoephedrine",
                    "relevance": "LOW"
                },
                {
                    "id": "M17410",
                    "name": "Nasal Decongestants",
                    "relevance": "LOW"
                },
                {
                    "id": "M21137",
                    "name": "Respiratory System Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20746",
                    "name": "Adrenergic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M3668",
                    "name": "Adrenergic alpha-Agonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M3673",
                    "name": "Adrenergic Agonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M20504",
                    "name": "Neurotransmitter Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M21869",
                    "name": "Protective Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "PhSol",
                    "name": "Pharmaceutical Solutions"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "CaAg",
                    "name": "Cardiotonic Agents"
                },
                {
                    "abbrev": "VaCoAg",
                    "name": "Vasoconstrictor Agents"
                },
                {
                    "abbrev": "Resp",
                    "name": "Respiratory System Agents"
                },
                {
                    "abbrev": "CNSSti",
                    "name": "Central Nervous System Stimulants"
                }
            ]
        }
    },
    "hasResults": false
}